|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Agenda Items
|
||||||||||||||||||||||
|
1 - Opening and constitution of Meeting Council
|
||||||||||||||||||||||
|
2 - Authorizing Meeting Council to sign the Annual General Meeting Minutes
|
||||||||||||||||||||||
|
3 - Review, discussion and approval of the Board of Directors' Activity Report pertaining to the fiscal year 2025
|
||||||||||||||||||||||
|
4 - Review of the Summary Independent Audit Report for the fiscal year 2025
|
||||||||||||||||||||||
|
5 - Review, discussion and approval of the Financial Statements for the fiscal year 2025
|
||||||||||||||||||||||
|
6 - Discussion of the release of each member of the Board of Directors of liability related to activities of the Company during the year 2025
|
||||||||||||||||||||||
|
7 - Discussion and approval of profit distribution proposal by the Board of Directors for the fiscal year 2025
|
||||||||||||||||||||||
|
8 - Submitting to the approval of the General Assembly the granting of authority to the Board of Directors to resolve on the distribution of Advance Dividend Payment in the event that profit is generated during the 2026 fiscal year
|
||||||||||||||||||||||
|
9 - Election of our Independent Board Members and the determination of their terms of office in accordance with the Corporate Governance Communiqué No. II-17.1 of the Capital Markets Board
|
||||||||||||||||||||||
|
10 - Discussion and approval of the amount of remuneration and attendance fee of the members of the Board of Directors
|
||||||||||||||||||||||
|
11 - Approval of the Independent Audit Company for the fiscal year 2026 recommended by the Board of Directors in accordance with the Company's related Audit Committee report pursuant to the Turkish Commercial Code and the regulations of the Capital Markets Board
|
||||||||||||||||||||||
|
12 - Informing shareholders about the donations granted during the fiscal year of 2025
|
||||||||||||||||||||||
|
13 - Informing shareholders about securities-pledges, mortgages and acquired incomes and benefits given in favour of third parties during the fiscal year of 2025
|
||||||||||||||||||||||
|
14 - Informing shareholders about transactions stated in principles 1.3.6 and 1.3.7 (Annex -1) of Capital Markets Board's Corporate Governance Communique no II.17.1
|
||||||||||||||||||||||
|
15 - Informing shareholders regarding transactions with related parties during the fiscal year 2025
|
||||||||||||||||||||||
|
16 - Granting authorization to the Chairperson and Members of the Board to make transactions written in articles 395 and 396 of Turkish Commercial Code
|
||||||||||||||||||||||
|
17 - Discussion of opinions, questions and wishes
|
||||||||||||||||||||||
|
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
-
|